A PNAS Direct Submission (2009). Test if α-synuclein pathology involves direct neuron-to- neuron transmission of α-synuclein aggregates via endocytosis.

Slides:



Advertisements
Similar presentations
Role of Cellular Mg 2+ in Modulating Collagen Deposition and Enzyme Efficiency in Hepatocytes and Kupffer Cells Steven Ewart 1, Andrea Romani 2 1 Dept.
Advertisements

 Dominant neurodegenerative disease  Polyglutamine repeat expansions (CAG, codon, Q) in exon 1 of huntingtin gene (htt). Usually >35 CAG repeats. 
Supplementary Methods TEM (transmission electron microscopy). TEM analysis were performed on EF-TEM LEO 912AB (Carl Zeiss Inc., Germany, Korea Basic Science.
Α-synuclein, Lewy Bodies, Prions, and Parkinson’s Disease Cody McCullough & Sara Homsi BCM 465 April 19 th, 2010.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Figure 3 Purpose: To further characterize cell-to-cell transmission of α- synuclein using an in vitro coculture model Figure 3(A) Hypothesis: If myc-tagged.
Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor.
Figure 1. Intact autophagosome–lysosome fusion, but impaired autolysosome clearance in NPC1-deficient cells. (A) Representative images of human dermal.
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Figure 8. Colocalization of β-Arrestin2-GFP with Internalized wt and S(483–498)A Mutant PTHRs HEK-wt PTHR and HEK-S(483–498)A PTHR cells were transiently.
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Loss of Bin1 Promotes the Propagation of Tau Pathology
Volume 14, Issue 5, Pages (November 2008)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
The Small-Molecule Iron Transport Inhibitor Ferristatin/NSC Promotes Degradation of the Transferrin Receptor  Lior Horonchik, Marianne Wessling-Resnick 
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Localization of B4GALNT2 and its role in mouse embryo attachment
Volume 137, Issue 1, Pages e3 (July 2009)
Smad7 gene transfer inhibits peritoneal fibrosis
Exosomes/microvesicles as a mechanism of cell-to-cell communication
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Intranigral Transplantation of Epigenetically Induced BDNF-Secreting Human Mesenchymal Stem Cells: Implications for Cell-Based Therapies in Parkinson's.
Pancreatic acinar cell dysfunction in CFTR−/− mice is associated with impairments in luminal pH and endocytosis  Steven D. Freedman, Horst F. Kern, George.
Volume 20, Issue 3, Pages (September 2016)
Growth Arrest Failure, G1 Restriction Point Override, and S Phase Death of Sensory Precursor Cells in the Absence of Neurotrophin-3  Wael M ElShamy, Lena.
Volume 125, Issue 1, Pages (July 2003)
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology
PRL-3 Promotes the Malignant Progression of Melanoma via Triggering Dephosphorylation and Cytoplasmic Localization of NHERF1  Xian-Ying Fang, Ran Song,
Michel Goedert, Florence Clavaguera, Markus Tolnay 
Volume 50, Issue 2, Pages (April 2006)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 72, Issue 1, Pages (October 2011)
Volume 140, Issue 2, Pages (February 2011)
Volume 13, Issue 4, Pages (October 2015)
Volume 50, Issue 2, Pages (April 2006)
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Volume 21, Issue 1, Pages (January 2013)
Serotonin Regulates the Secretion and Autocrine Action of a Neuropeptide to Activate MAPK Required for Long-Term Facilitation in Aplysia  Jiang-Yuan Hu,
Volume 4, Issue 1, Pages (July 2013)
Volume 64, Issue 5, Pages (December 2009)
Volume 4, Issue 1, Pages (July 2013)
The pathological role of Bax in cisplatin nephrotoxicity
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
Volume 22, Issue 1, Pages (January 2018)
Gillian Elliott, Peter O'Hare  Cell 
Overexpression of HGF decreases MET protein levels.
Nerve Growth Factor Receptor-Mediated Gene Transfer
EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy
Volume 121, Issue 4, Pages (October 2001)
The PAR-6 Polarity Protein Regulates Dendritic Spine Morphogenesis through p190 RhoGAP and the Rho GTPase  Huaye Zhang, Ian G. Macara  Developmental Cell 
Volume 90, Issue 3, Pages (August 1997)
Volume 7, Issue 6, Pages (June 2014)
Impaired Trafficking of the Desmoplakins in Cultured Darier's Disease Keratinocytes  Jittima Dhitavat, Christian Cobbold, Natalie Leslie, Susan Burge,
Translocation of a Vibrio cholerae Type VI Secretion Effector Requires Bacterial Endocytosis by Host Cells  Amy T. Ma, Steven McAuley, Stefan Pukatzki,
Volume 90, Issue 3, Pages (May 2016)
A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy 汇报人:宋雨田 IMI.
Volume 12, Issue 1, Pages (January 2019)
Volume 98, Issue 3, Pages (August 1999)
MCSA Journal Club January 2019
Volume 128, Issue 3, Pages (March 2005)
Yoshinori Aragane, Akira Maeda, Chang-Yi Cui, Tadashi Tezuka 
Geldanamycin-induced endocytosis and down-regulation of ErbB2 in cells expressing ErbB2 only. Geldanamycin-induced endocytosis and down-regulation of ErbB2.
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Exosomal DNA Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson’s Disease Model  Xiaoxi Ren, Yun Zhao, Fenqin.
Fig. 2. TH expression is decreased in mice with HFD-induced obesity
Volume 15, Issue 5, Pages (May 2007)
Engraftment of Bone Marrow–derived Stem Cells to the Lung in a Model of Acute Respiratory Infection by Pseudomonas aeruginosa  Joanna Rejman, Carla Colombo,
Translocation of a Vibrio cholerae Type VI Secretion Effector Requires Bacterial Endocytosis by Host Cells  Amy T. Ma, Steven McAuley, Stefan Pukatzki,
Presentation transcript:

A PNAS Direct Submission (2009)

Test if α-synuclein pathology involves direct neuron-to- neuron transmission of α-synuclein aggregates via endocytosis Overall hypothesis: If α-synuclein aggregates can be spread by direct neuron-to-neuron transmission, then we would expect accumulation of α-synuclein aggregates in the uninfected neurons. Desplats Paper

Figure 1 Figure 1A and 1B Hypothesis: If extracellular α-synuclein can be taken up by the mouse cortical neuronal stem cells (MCNSCs), then α-synuclein accumulation will be detected in the MCNSCs via Western blot and fluorescent microscopy.

Alexa-Fluor-488-α-synuclein MCNSCs Polyornithine/laminin-coated plate E15-E18 C57/BL6

Western Blotting

Figure 1(A): Results MCNSCs capable of taking up extracellular α-synuclein ? Conclusions?

Confocal Microscopy

Figure 1(B): Results MCNSCs took up extracellular Alexa-Fluor-488-labeled α-synuclein Conclusions?

Figure 1(C) Purpose: To determine whether α-synuclein released from neuronal cells can be directly transferred to MCNSCs Hypothesis: If α-synuclein is released by the neuronal cells, then we would expect to see uptake of α-synuclein in the MCNSCs via immunofluoresence.

Figure 1(C) Donor Cells Acceptor Cells MCNSCs-GFP Rat B103 + α-synuclein

Immunofluorescence α-synuclein

Figure 1(C): Results 47% of MCNSCs showed patterns of cytoplasmic accumulation of α-synuclein MCNSCNeuronal Cells Neuronal Cells + MCNSC Conclusions?

Figure 2 Purpose: To analyze the propagation of α-synuclein to transplanted stem cells in vivo. Figure 2 A-C Hypothesis: If a-syn can be transmitted directly from host to grafted neuronal stem cells, then α-synuclein will be detected in MCNSCs grafted into transgenic mice via immunofluoresence.

Immunostaining and TSA Adopted from HRP tyramide red α-syn HRP Secondary Antibody

Figure 2 Injected GFP-labeled MCNSCs into the hippocampus of transgenic mice expressing human α-synuclein. Transgenic (expresses human α-synuclein via Thy-1 promoter)

Figure 2 (A-C): Results ≈2.5% of MCNSCs showed human α-synuclein immunoreactivity in transgenic mice after 1 week 1 Week Later Hippocampus

Figure 2 (D-E): Results When MCNSCs not injected into α-synuclein transgenic mice, no immunoreactivity (D) MCNSCs showed no human α-synuclein immunoreactivity in non-transgenic mice (E) Controls

Figure 2 (F): Results 15% of α-synuclein-positive MCNSCs developed LBs in cytoplasm after 4 weeks 4 Weeks Later MCNSCs α-synuclein transgenic α-synuclein transgenic + MCSNCs

Figure 2 (G): Results Comments? 2.5% 15%

Figure 2 Suggests that α-synuclein pathology can be transmitted directly from host to grafted cells

Figure 3 Purpose: To further characterize cell-to-cell transmission of α- synuclein using an in vitro coculture model Figure 3(A) Hypothesis: If myc-tagged α-synuclein from donor cells can be released and transmitted to SH-SY5Y acceptor cells, then α- synuclein will be detected in the donor cells via immunofluorescence.

Figure 3 SH-SY5Y SH-SY5Y + α-synuclein myc SH-SY5Y Q Q Q Q Q Donor Cells Acceptor Cells

Figure 3(A): Results After 24 hrs, myc-tagged α-synuclein from donor cells was detected in acceptor cells Formation of inclusion bodies in some acceptors cells Conclusions?

Figure 3(A): Results After 24 hrs, myc-tagged α-synuclein from donor cells was detected in acceptor cells Formation of inclusion bodies in some acceptors cells Conclusions?

Figure 3(B): Results Inclusion body formation occurs with prolonged transmission of α-synuclein Conclusions?

Figure 3(C): Results ~ ½ of the acceptor cells displayed ubiquitin immunoreactivity Conclusions?

Figure 3(D) Purpose: To examine the involvement of donor cell membrane leakage in transmission of α-synuclein Lactate dehydrogenase release (LDH) assay SH-SY5Y cells overexpressing β-galatosidase, α- synuclein, and α-synuclein-myc

Figure 3(D): Results Cell-to-cell transmission occurs without cellular membrane leakage Conclusions?

Supplemental Fig. S2A Purpose: To determine if cell-cell contact is required for inclusion body formation – SH-SY5Y cells incubated in medium from SH-SY5Y cells expressing myc-tagged α-synuclein. Hypothesis: If cell-cell contact is not required for inclusion body formation, then inclusion bodies will be detected in the cells in which α-synuclein was taken up.

Results: Fig. S2A α-synuclein inclusion bodies formed in the neuronal stem cells Conclusions?

Supplemental Fig. S3A Purpose: To determine if transmission of α-synuclein aggregates is dependent on endocytosis – Dynamin-1 K44A expressed in acceptor cells (blocks endocytic formation) – Donor cells cocultured with acceptor cells Hypothesis: If transmission of α-synuclein aggregates is dependent on endocytosis, then we would detect a reduction in the uptake of α-synuclein in the cells expressing dynamin-1 K44A.

Results: Fig. S3A Transmission of α-synuclein significantly reduced in acceptor cells Conclusions?

Figure 4 Purpose: To determine the role of quality control failure in deposition of α-synuclein Hypothesis: If protein quality control systems are impaired due to being in the presence of MG132 proteosomal inhibitor or Baf A1 lysosomal inhibitor, then we would expect increased accumulation of transmitted α-synuclein in the cells.

myc-α-synuclein Figure 4 SH-SY5Y Baf A1

myc-α-synuclein Figure 4 SH-SY5Y MG132

Figure 4(A-B): Results Conclusions? Increased α-synuclein accumulation by lysosomal failure but no effect on proteosomal inhibition